COVID-19 infection in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab

A patient with severe CRSwNP, asthma, and NSAIDS received dupilumab treatment. Three weeks after therapy onset, the patient was diagnosed with Covid-19, had a mild course of the disease, and fully recovered from the infection.

Source: Journal of Allergy and Clinical Immunology - May 13, 2020 Category: Allergy & Immunology Authors: Ulrike F örster-Ruhrmann, Agnieszka J. Szczepek, habil Claus Bachert, habil Heidi Olze Source Type: research